Market Overview

Sanofi Q2 Net Profit Surges 16%

Share:
Related SNY
ENGAGE Randomized Clinical Trial Evaluating Cerdelgafor Treatment-Naïve Patients with Gaucher Disease Type 1 Published in The Journal of the American Medical Association
Sanofi Posts Higher Q4 Profit
Seeking Alpha's Biotech Weekly: Achillion Overdone, Sanofi's Toujeo A Go, And More (Seeking Alpha)

Sanofi SA (NYSE: SNY) posted a rise in its second-quarter net profit.

Sanofi's net profit attributable to shareholders climbed 16% to 1.17 billion euros (US$1.4 billion), versus EUR1.01 billion, in the year-ago period. Its business net income fell 9.6% to EUR1.94 billion.

Analysts were expecting a business net profit of EUR1.88 billion. Its net sales gained 6.2% to EUR8.87 billion.

Sanofi shares closed at $37.85 yesterday.

Posted-In: profitEarnings News

 

Related Articles (SNY)

Around the Web, We're Loving...

Get Benzinga's Newsletters